Parte, Capitolo, Paragrafo

 1 I, 1,1(4)   |      Tzakis A.G., et al. Baboon to human liver transplantation, Lancet,
 2 I, 1,1(10)  |             Martin M.J., et al., A human CD46 transgenic pig model
 3 I, 2,2(15)  | carbohydrate structures which bind human antiporcine antibodies:
 4 I, 2,2(15)  |         Anti-pig IgM antibodies in human serum react predominantly
 5 I, 2,2(16)  |              Removal of baboon and human antiporcine IgG and IgM
 6 I, 2,2(16)  |     anti-pig xenoantibodies in the human by plasmapheresis/immunoadsorption,
 7 I, 2,2(19)  |             Martin M.J., et al., A human CD46 transgenic pig model
 8 I, 2,2(19)  |         Expression of a functional human complement inhibitor in
 9 I, 2,2(19)  |             Alvarado C.G., et al., Human complement regulatory proteins
10 I, 2,2(19)  |           of pigs transgenic for a human regulator of complement
11 I, 2,2(20)  |         cell substantially reduces human antibody binding and complement-mediated
12 I, 2,3(34)  |             Alvarado C.G., et al., Human complement regulatory proteins
13 I, 2,3(34)  |           transgenic expression of human decay-accelerating factor
14 I, 2,3(35)  |             Alvarado C.G., et al., Human complement regulatory proteins
15 I, 2,4(42)  |       Weiss RA, 1997, Infection of human cells by an endogenous retrovirus
16 II, 2,12(65)|            2000; U.S. Dpt. Healt & Human Services, Food and Drug
17 II, 3,21(75)|           Department of Health and Human Services Committee on Xenotransplantation,